Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...

First, a bit of background on the pain-drug environment ... That's why, following this recent FDA approval, Vertex stock makes a no-brainer biotech stock to buy and hold for the long term.

Mistral, the company sometimes considered Europe’s great hope for AI, is releasing several updates to its AI assistant, Le ...

For the next few weeks, the planet Mars will form an isosceles triangle with the two bright stars marking the heads of the ...

Keep your eye on the ball” is a motto for many athletes—and for astronomers trying to find Earth-threatening space rocks ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from In-Line to Outperform. Analyst Price Forecast Suggests 90.46% Upside As ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...

During the Men’s and Women’s Snowboard SuperPipe finals on Thursday and Saturday, the system, which uses Google Cloud tools including Vertex AI and ... and will have no affect on final scoring.

Vertex Pharmaceuticals is working toward making its recently approved non-opioid pain medicine Journavx not only broadly ...